Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment.
about
Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in OsteomyelitisAntimicrobial peptides and complement in neonatal hypoxia-ischemia induced brain damageHost defense peptides of thrombin modulate inflammation and coagulation in endotoxin-mediated shock and Pseudomonas aeruginosa sepsisStructure, Dynamics, and Antimicrobial and Immune Modulatory Activities of Human LL-23 and Its Single-Residue Variants Mutated on the Basis of Homologous Primate CathelicidinsRoles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseasesUltrashort cationic lipopeptides and lipopeptoids selectively induce cytokine production in macrophagesAbility of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal modelsThe two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRSPerspectives for clinical use of engineered human host defense antimicrobial peptidesNeutrophil depletion suppresses pulmonary vascular hyperpermeability and occurrence of pulmonary edema caused by hantavirus infection in C.B-17 SCID mice.A peptide of heparin cofactor II inhibits endotoxin-mediated shock and invasive Pseudomonas aeruginosa infection.Epinecidin-1 has immunomodulatory effects, facilitating its therapeutic use in a mouse model of Pseudomonas aeruginosa sepsisInnate defense regulator peptide 1018 in wound healing and wound infectionHost defense peptides: an alternative as antiinfective and immunomodulatory therapeutics.Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation.Structure-activity studies and therapeutic potential of host defense peptides of human thrombin.The TFPI-2 derived peptide EDC34 improves outcome of gram-negative sepsis.Modulation of interleukin-1β-induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblastsMaximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine productionImmunomodulatory and Anti-Inflammatory Activities of Chicken Cathelicidin-2 Derived Peptides.High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides.Synthetic mimics of antimicrobial peptides with immunomodulatory responsesThe role of the Src family kinase Lyn in the immunomodulatory activities of cathelicidin peptide LL-37 on monocytic cells.Protective effect of in ovo treatment with the chicken cathelicidin analog D-CATH-2 against avian pathogenic E. coliWnt5a stimulates chemotactic migration and chemokine production in human neutrophilsIdentification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infectionIn vitro testing of African traditional medicines for cytotoxic, immune modulatory and anti-HIV activities.Nematode Peptides with Host-Directed Anti-inflammatory Activity Rescue Caenorhabditis elegans from a Burkholderia pseudomallei Infection.A novel C5a-derived immunobiotic peptide reduces Streptococcus agalactiae colonization through targeted bacterial killing.An anti-infective synthetic peptide with dual antimicrobial and immunomodulatory activities.Peptide design for antimicrobial and immunomodulatory applications.Avian antimicrobial host defense peptides: from biology to therapeutic applications.Evaluation of the Immunomodulatory Activity of the Chicken NK-Lysin-Derived Peptide cNK-2.Bacterial resistance mechanisms against host defense peptides.Modulating immunity as a therapy for bacterial infections.Cationic host defence peptides: multifaceted role in immune modulation and inflammation.Immunotherapy for pulmonary TB: antimicrobial peptides and their inducers.Immune modulation by multifaceted cationic host defense (antimicrobial) peptides.Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections.Therapeutic utility of antibacterial peptides in wound healing.
P2860
Q26774480-5FF9B419-D749-417B-983E-FF0021EC4D7CQ26850135-C9CD1C0B-A060-4726-A72D-4D7F468233D6Q27331817-C5A47D46-95D6-4CE0-B124-967B253335EDQ27676333-9FB67BC5-5947-4084-9F17-2FDF96EDEF79Q28079028-ABFF9A22-5A97-4CF4-9DD4-A43CE50FEB4AQ28485935-8EB81EBD-93A7-44AF-82C8-27791C3795B9Q28488709-EDDA99D4-97E1-4817-837E-9039204389F0Q28492572-7E1122BC-C92E-4770-A7FA-724D4D699712Q33700825-18233222-AAC3-4291-A2A3-FC5238A67901Q33743958-478B2834-D308-4A04-AE34-1429581EA771Q33927961-68D14B8D-CABE-49DC-92A3-B040F57BA54DQ34058050-290D7D4A-97DC-41E3-A838-351E09E4E9F0Q34373912-7EE5824A-0AA9-45A4-BB65-C6B8C108A054Q34495298-BE3C6808-6C60-4850-B2BE-397A0C20BC55Q34544517-E0CE96E9-1C94-4849-B0AE-2F54930F92F3Q35004988-27C136CA-FC65-4D57-9BE3-4115C70F86B2Q35067228-B559E7B3-45CB-47A5-947F-EC66F1C1DB5BQ35617710-6461E000-D84D-479B-B82D-5E2F50443884Q35802766-63081C5E-1DC9-4694-813D-498EB6470263Q35915514-0980C69F-9467-4C28-8C7F-E82CC6580FA5Q36090102-783D5214-77DC-414F-A81F-0540ADC728A3Q36122395-C6D41EAE-A011-47D3-9648-E362A468DF44Q36132248-3613B7AF-2B23-4E44-B37A-15CCECFB84D9Q36941335-604EC263-9DEE-4FDD-84C9-D031E88419B7Q36982055-E8AF58CC-4D86-48B1-8513-C952BC2D28D7Q37036638-6F648149-C21C-48D8-A29E-905A8CCF137BQ37103094-1A2126E3-50A3-49C7-A76A-ED8A79EC5076Q37248305-A98CC94E-27E2-492A-AF72-8CE868957AE0Q37263526-4DEBB185-BFA3-4DC5-B886-5F7A7CFC4276Q37386135-CE6A8EF7-5D3E-4BDA-A3C7-511B3EBA6672Q37598400-2A20F8DF-2F7B-4D3C-81F5-C96AE2D99C2CQ37689800-B808E319-9A33-445C-98E4-CF314E242D3CQ37717143-4D7D2479-A66D-4C83-9E42-0C2CC8C83545Q37874201-3BEDF6C2-508A-43C6-9229-88AB86B82F65Q37994068-BAAFEC72-F90D-470C-9374-E9520479375AQ38022156-C3D5AF77-3319-4C16-B573-F299F6504E98Q38148589-557C2EA3-918D-4827-B293-2B21AF059972Q38162670-7FA71BBF-79D1-4CC6-8548-B338533850C3Q38263995-ECA247AE-A271-4329-AEB4-7690B984C69DQ38401924-84452927-C455-4599-A0E6-DE39A1B1A05D
P2860
Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Synthetic cationic peptide IDR ...... nhanced leukocyte recruitment.
@ast
Synthetic cationic peptide IDR ...... nhanced leukocyte recruitment.
@en
Synthetic cationic peptide IDR ...... nhanced leukocyte recruitment.
@nl
type
label
Synthetic cationic peptide IDR ...... nhanced leukocyte recruitment.
@ast
Synthetic cationic peptide IDR ...... nhanced leukocyte recruitment.
@en
Synthetic cationic peptide IDR ...... nhanced leukocyte recruitment.
@nl
prefLabel
Synthetic cationic peptide IDR ...... nhanced leukocyte recruitment.
@ast
Synthetic cationic peptide IDR ...... nhanced leukocyte recruitment.
@en
Synthetic cationic peptide IDR ...... nhanced leukocyte recruitment.
@nl
P2093
P50
P356
P1476
Synthetic cationic peptide IDR ...... nhanced leukocyte recruitment.
@en
P2093
Anastasia Nijnik
Donna M Easton
Laurence Madera
Matthew L Mayer
Matthew Waldbrook
Melissa R Elliott
Sarah C Mullaly
P304
P356
10.4049/JIMMUNOL.0901813
P407
P577
2010-01-27T00:00:00Z